These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26399862)

  • 1. Utility of molecular testing in the management of thyroid nodules - a clinical perspective.
    Elaraj D; Nayar R; Sturgeon C
    Cytopathology; 2015 Oct; 26(5):284-7. PubMed ID: 26399862
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the role of molecular markers in the management of "indeterminate" thyroid nodules?
    Daniels GH
    Cancer Cytopathol; 2013 May; 121(5):223-4. PubMed ID: 23670834
    [No Abstract]   [Full Text] [Related]  

  • 3. Lessons from early clinical experience with the Afirma gene expression classifier.
    Krane JF
    Cancer Cytopathol; 2014 Oct; 122(10):715-9. PubMed ID: 25123593
    [No Abstract]   [Full Text] [Related]  

  • 4. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indeterminate Thyroid Nodules and Advances in Molecular Pathology.
    Belovarac B; Zhou F; Sharma J; Brandler TC
    Semin Diagn Pathol; 2023 Sep; 40(5):349-352. PubMed ID: 37173165
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Endo M; Nabhan F; Angell TE; Harrell RM; Nasr C; Wei S; Sipos JA
    Thyroid; 2020 Sep; 30(9):1390-1392. PubMed ID: 32228149
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular cytopathology for thyroid nodules: A review of methodology and test performance.
    Nishino M
    Cancer Cytopathol; 2016 Jan; 124(1):14-27. PubMed ID: 26348024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dignity of thyroid nodules: diagnostic gain by molecular fine needle aspiration cytology].
    Eszlinger M; Ruschenburg I; Paschke R
    Dtsch Med Wochenschr; 2013 Oct; 138(40):2003-6. PubMed ID: 24065405
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of fine-needle aspiration and fine-needle capillary sampling of thyroid nodules: a prospective study with emphasis on the influence of nodule size.
    Zhou JQ; Zhang JW; Zhan WW; Zhou W; Ye TJ; Zhu Y; Yao JJ; Liu J; Hu YY; Grant EG
    Cancer Cytopathol; 2014 Apr; 122(4):266-73. PubMed ID: 24302655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
    Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
    Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
    Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
    J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine needle aspiration biopsy of thyroid nodules in children and adolescents.
    Chang SH; Joo M; Kim H
    J Korean Med Sci; 2006 Jun; 21(3):469-73. PubMed ID: 16778391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of molecular markers in pre-operative assessment of thyroid nodules.
    Bhatia P; Abd Elmageed ZY; Friedlander P; Aslam R; Kandil E
    Future Oncol; 2015; 11(16):2343-50. PubMed ID: 26260812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fine-needle aspiration biopsy in the management of palpable thyroid nodules.
    Greenspan FS
    Am J Clin Pathol; 1997 Oct; 108(4 Suppl 1):S26-30. PubMed ID: 9322610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.
    Kwon HJ; Kim EK; Kwak JY
    Pathol Res Pract; 2015 Sep; 211(9):671-6. PubMed ID: 26187369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular diagnosis and management of thyroid neoplasms.
    Theoharis C; Roman S; Sosa JA
    Curr Opin Oncol; 2012 Jan; 24(1):35-41. PubMed ID: 22123232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental utility of expanded mutation panel when used in combination with microRNA classification in indeterminate thyroid nodules.
    Jackson S; Kumar G; Banizs AB; Toney N; Silverman JF; Narick CM; Finkelstein SD
    Diagn Cytopathol; 2020 Jan; 48(1):43-52. PubMed ID: 31675178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-needle aspiration biopsy of thyroid nodules: Determining when it is necessary.
    Song JSA; Hart RD
    Can Fam Physician; 2018 Feb; 64(2):127-128. PubMed ID: 29449244
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.
    Keutgen XM; Filicori F; Fahey TJ
    Expert Rev Mol Diagn; 2013 Jul; 13(6):613-23. PubMed ID: 23895130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.